Literature DB >> 20080199

Dysregulated microRNAs in neurodegenerative disorders.

Pierre Lau1, Bart de Strooper.   

Abstract

The complexity of the nervous system arises in part, from the large diversity of neural cell types that support the architecture of neuronal circuits. Recent studies have highlighted microRNAs as important players in regulating gene expression at the post-transcriptional level and therefore the phenotype of neural cells. A link between microRNAs and neurodegenerative diseases such as Alzheimer's disease, Huntington's disease and Parkinson's disease is becoming increasingly evident. Here, we discuss microRNAs in neurodegeneration, from the fruit fly and mouse utilized as experimental models to dysregulated microRNAs in human neurodegenerative disorders. We propose that studying microRNAs and their mRNA targets in the context of neurodegeneration will significantly contribute to the identification of proteins important for neuronal function and might reveal underlying molecular networks that drive these diseases. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20080199     DOI: 10.1016/j.semcdb.2010.01.009

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  53 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  microRNA-34c is a novel target to treat dementias.

Authors:  Athanasios Zovoilis; Hope Y Agbemenyah; Roberto C Agis-Balboa; Roman M Stilling; Dieter Edbauer; Pooja Rao; Laurent Farinelli; Ivana Delalle; Andrea Schmitt; Peter Falkai; Sanaz Bahari-Javan; Susanne Burkhardt; Farahnaz Sananbenesi; Andre Fischer
Journal:  EMBO J       Date:  2011-09-23       Impact factor: 11.598

3.  HIV-1 Tat protein promotes neuronal dysfunction through disruption of microRNAs.

Authors:  J Robert Chang; Ruma Mukerjee; Asen Bagashev; Luis Del Valle; Tinatin Chabrashvili; Brian J Hawkins; Johnny J He; Bassel E Sawaya
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

4.  miR-186 is decreased in aged brain and suppresses BACE1 expression.

Authors:  Jaekwang Kim; Hyejin Yoon; Dah-Eun Chung; Jennifer L Brown; Krystal C Belmonte; Jungsu Kim
Journal:  J Neurochem       Date:  2016-03-30       Impact factor: 5.372

5.  MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.

Authors:  Sabrina Absalon; Dawn M Kochanek; Venkatesan Raghavan; Anna M Krichevsky
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

6.  Distinct, sex-dependent miRNA signatures in piglet hippocampus induced by a clinically relevant isoflurane exposure: a pilot study.

Authors:  Emmett E Whitaker; Brianne Z Wiemann; Jason C Xia; Bruno Bissonnette; Joseph Liu; Paolo Fadda; Joseph D Tobias; Fievos L Christofi
Journal:  J Anesth       Date:  2019-10-14       Impact factor: 2.078

7.  The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration.

Authors:  Silvia Moncini; Alessandro Salvi; Paola Zuccotti; Gabriella Viero; Alessandro Quattrone; Sergio Barlati; Giuseppina De Petro; Marco Venturin; Paola Riva
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

Review 8.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

9.  Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin.

Authors:  Jing Jin; Yong Cheng; Yongqing Zhang; William Wood; Qi Peng; Emmette Hutchison; Mark P Mattson; Kevin G Becker; Wenzhen Duan
Journal:  J Neurochem       Date:  2012-09-28       Impact factor: 5.372

10.  Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.

Authors:  Nicole Schonrock; Yazi D Ke; David Humphreys; Matthias Staufenbiel; Lars M Ittner; Thomas Preiss; Jürgen Götz
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.